Comparative Trial of Oral Penicillin Versus Cefuroxim for Treatment of Perianal Streptococcal Dermatitis
NCT00261742 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 194
Last updated 2007-01-17
Summary
The goal of the study is to investigate, which of two antibiotic treatments - oral penicillin for 10 days or oral cefuroxim for 7 days - is more successful for patients (1-16 years of age) with perianal dermatitis caused by group A beta-hemolytic streptococci.
Conditions
- Streptococcal Infections
Interventions
- DRUG
-
Penicillin versus cefuroxim per os
Sponsors & Collaborators
-
University Children's Hospital Basel
lead OTHER
Principal Investigators
-
Ulrich Heininger, MD · University Children's Hospital Basel
-
Urs B Schaad, MD · University Children's Hospital Basel
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 1 Year
- Max Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2005-10-31
- Completion
- 2006-12-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Efficacy, Safety, and Tolerability of TD1414 2% Cream in Impetigo and Secondarily Infected Traumatic Lesions (SITL)
NCT00626795 ·Status: COMPLETED ·Phase: PHASE2
-
Safety & Efficacy of Daptomycin Versus Standard of Care (SOC) in 1 - 17 Year Olds With Staphylococcus Aureus Bacteremia (MK-3009-005)
NCT01728376 ·Status: COMPLETED ·Phase: PHASE4
-
Oral-only Antibiotics for Bone and Joint Infections in Children
NCT04563325 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
NCT00621192 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
S. Aureus Decolonization in HPN Patients.
NCT03173053 ·Status: TERMINATED ·Phase: NA
-
Safety and Efficacy Study of Daptomycin in Pediatric Participants (1 to 17 Years-old) With Skin and Skin Structure Infections
NCT00711802 ·Status: COMPLETED ·Phase: PHASE4
-
Safety, Potential Efficacy, and Pharmacokinetics of PZ-601 in the Treatment of Complicated Skin and Skin Structure Infection
NCT00671580 ·Status: COMPLETED ·Phase: PHASE2
-
Safety, Efficacy, and Pharmacokinetics (PK) of Daptomycin (MK-3009) in Japanese Pediatric Subjects With Complicated Skin and Soft Tissue Infections (cSSTI) and Bacteremia (MK-3009-029)
NCT03643952 ·Status: COMPLETED ·Phase: PHASE2
-
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
NCT00691600 ·Status: COMPLETED ·Phase: PHASE3
-
Ceftobiprole in the Treatment of Resistant Staphylococcus Aureus Skin and Skin Structure Infections
NCT00210899 ·Status: COMPLETED ·Phase: PHASE3
-
The Importance of Anti-anaerobic Therapy for Acute Pelvic Inflammatory Disease (PID)
NCT01160640 ·Status: COMPLETED ·Phase: PHASE2
-
Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia
NCT03439124 ·Status: COMPLETED ·Phase: PHASE3
-
A Single-Dose Pharmacokinetics and Safety Study of Ceftobiprole in Pediatric Patients =3 Months to <18 Years of Age
NCT01026636 ·Status: COMPLETED ·Phase: PHASE1
-
Comparison of Cephalexin Versus Clindamycin for Suspected CA-MRSA Skin Infections
NCT00352612 ·Status: COMPLETED ·Phase: PHASE4
-
Ceftobiprole in the Treatment of Hospitalized Patients With Staphylococcus Aureus Bacteremia
NCT00505258 ·Status: WITHDRAWN ·Phase: PHASE2
-
Safety and Efficacy of Mupirocin in Eradicating Colonization With S. Aureus in Critically Ill Infants
NCT01827358 ·Status: COMPLETED ·Phase: PHASE2
-
Pharmacokinetic and Safety Study of Metronidazole Oral Suspension in Pediatric Patients With Anaerobic Bacterial Infection
NCT07146217 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Cefadroxil and Cephalexin Drug Levels and Dosing in Pediatric Musculoskeletal Infections
NCT03802552 ·Status: COMPLETED ·Phase: PHASE1
-
Management of Vaginal Complaints: A Pilot Study Within a Practice-Based Research Network
NCT00503542 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Study of Single Dose Daptomycin in Pediatric Patients With Gram-positive Infection for Which They Are Receiving Standard Antibiotics
NCT00136292 ·Status: COMPLETED ·Phase: PHASE1
-
A Placebo-Controlled, Dose-Escalating Study to Examine the Safety and Tolerability of Single Intravenous Doses of CF-301 in Healthy Subjects
NCT02439359 ·Status: COMPLETED ·Phase: PHASE1
-
Oral Amoxicillin and Cephalexin PK/PD in Neonates
NCT04916951 ·Status: COMPLETED ·Phase: PHASE1
-
Infant Antibiotic Resistance and Implications for Therapeutic Decision-making
NCT01781182 ·Status: COMPLETED
-
Plasma Pharmacological Monitoring of M Penicillins in Methicillin-sensitive Staphylococcus Aureus Bacteremia
NCT06495697 ·Status: RECRUITING
-
Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline
NCT01724671 ·Status: UNKNOWN